// App-Quantinova.ai

7542 : Skin toxicity associated with outcome to erlotinib in non-small cell lung cancer (NSCLC) patients (p) with EGFR mutations in the EURTAC study.

Researchers

Presenter

  • Cristina Buges

Principal Investigators

  • Rafael Rosell

  • Enriqueta Felip

  • Margarita Majem

  • Rut Porta

  • Ramon Palmero

  • Ana Drozdowskyj

  • Cordula Heidecke

  • Amaya Gasco

  • Miquel Taron

  • Luis G. Paz-Ares

  • Alain Vergnenegre

  • Filippo De Marinis

  • Bartomeu Massuti

  • Javier De Castro

  • Radj Gervais

  • Enric Carcereny Costa

  • Teresa Moran

  • Mariacarmela Santarpia

Medical Centers

  • Hospital De Sant Pau, Barcelona, Spain

  • Cluzeau Hospital, Limoges, France

  • Hospital Verge de la Cinta, Tortosa, Spain

  • Department of Medical Oncology, Doce de Octubre University Hospital, Madrid, Spain

  • Hospital General de Elche, Alicante, Spain

  • Catalan Institute of Oncology, Hospital Duran i Reynals, L?Hospitalet, Spain

  • PIVOTAL, Madrid, Spain

  • University Hospital Vall d'Hebron, Barcelona, Spain

  • Medical Oncology University of Messina,., Messina, Italy

  • Centre Francois Baclesse, Caen, France

  • Pangaea Biotech, USP Institut Universitari Dexeus, Barcelona, Spain

Locations

  • France

  • Spain

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Circulating tumor cells

  • Epidermal growth factor receptor

Drug/Treatment

  • Erlotinib hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved